Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 483 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d569-3994-7205-af74-793eb74d68cd

adms:identifier	mi-legislature-measure 2023-2024/SB/483
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Darrin Camilleri
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0483 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0483
schema:legislationIdentifier	SB 483
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.en
schema:sponsor	Erika Geiss Sylvia A Santana Stephanie Chang Darrin Camilleri Dayna Polehanki Mary Cavanagh Jeremy Moss Mallory McMorrow Paul Wojno Veronica Klinefelt Rosemary Bayer Sue Shink Jeff Irwin Sarah E Anthony John Cherry Sam Singh Winnie Brinks Kristen McDonald Rivet
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-SB-0483
skos:prefLabel	SB 483 (2023-2024)en